Ameet Sarpatwari
7 Podcast Episodes
NEJM Interview: Dr. Ameet Sarpatwari on a legal case that could affect market entry of generic and biosimilar drugs.
NEJM Interview: Dr. Ameet Sarpatwari on a legal case that could affect market entry of generic and biosimilar drugs.
Dr. Ameet Sarpatwari is an assistant professor of medicine at Harvard Medical School and the assistant director of the P... Read more
8 Feb 2023
•
12mins
4.05 Exodus from Academia and the Regretful FDA Approval of Aducanumab with Dr. Ameet Sarpatwari
4.05 Exodus from Academia and the Regretful FDA Approval of Aducanumab with Dr. Ameet Sarpatwari
Today we are joined by Dr. Ameet Sarpatwari of Harvard Medical School to discuss how so many great minds in oncology are... Read more
7 Jul 2021
•
53mins
Similar People
Rachel Sachs
Aaron Kesselheim
Wendy Mariner
Mark Hall
Wendy Parmet
Holly Lynch
Michelle Mello
Erin Fuse Brown
George Annas
Stacie Dusetzina
Gilbert Welch
Patricia Zettler
Christopher Robertson
Walid Gellad
Amy Kapczynski
2.47 Remdesivir, Cloth Masks, & Incentives for COVID-19 Drug Development with Dr. Ameet Sarpatwari
2.47 Remdesivir, Cloth Masks, & Incentives for COVID-19 Drug Development with Dr. Ameet Sarpatwari
This week we start with an in-depth monologue on various new developments surrounding COVID-19, specifically the new stu... Read more
16 Apr 2020
•
1hr 16mins
1.53 CALGB 50303, REMoDL-B, & REMS, Orphan Drug Act, and Role of the FDA with Dr. Ameet Sarpatwari
1.53 CALGB 50303, REMoDL-B, & REMS, Orphan Drug Act, and Role of the FDA with Dr. Ameet Sarpatwari
We begin this episode with a discussion of two recent clinical trials in lymphoma: CALGB 50303 and REMoDL-B, respectivel... Read more
11 Apr 2019
•
1hr 46mins
Most Popular
Elon Musk
Barack Obama
Bill Gates
LeBron James
Mark Cuban
Michelle Obama
Melinda Gates
Arnold Schwarzenegger
Kevin Hart
Terry Crews
Mike Tyson
107. Prescription Drug Price Metrics. Guests, Aaron Kesselheim & Ameet Sarpatwari.
107. Prescription Drug Price Metrics. Guests, Aaron Kesselheim & Ameet Sarpatwari.
Two of the nation’s leading researchers into prescription drug costs join us for an in-depth exploration of the reasons ... Read more
4 Aug 2017
•
40mins
67. This One is a Little Wonky. Guest, Ameet Sarpatwari.
67. This One is a Little Wonky. Guest, Ameet Sarpatwari.
A wide-ranging discussion of drug innovation issues with Harvard lawyer-epidemiologist Ameet Sarpatwari, plus a lightnin... Read more
30 Aug 2016
•
38mins
Dr. Ameet Sarpatwari on state bills that aim to reduce drug spending by requiring companies to disclose R&D costs.
Dr. Ameet Sarpatwari on state bills that aim to reduce drug spending by requiring companies to disclose R&D costs.
Dr. Ameet Sarpatwari is an epidemiologist in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and W... Read more
15 Jun 2016
•
9mins
